Skip to Main Content

Paper Details

Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy.
Cancer Cell
36
2023
-, CR, FGF2, HPD, ICB, IFN, NAD, PKM2, SIRT1, T cell, cancer, catenin, enhanced -catenin, hyperprogressive disease, interferon, interferon (IFN) gene signature, patients, tumor, tumor FGF2, tumor stemness, tumor-infiltrating CD8 T cells, tumors
Author NameAffiliation
Marcin CieslikUniversity of Michigan, USA Michigan Center for Translational Pathology ann arbor
Arul M ChinnaiyanUniversity of Michigan, USA Michigan Center for Translational Pathology, USA Howard Hughes Medical Institute ann arbor
Arul M ChinnaiyanUniversity of Michigan, USA Michigan Center for Translational Pathology, USA Howard Hughes Medical Institute ann arbor
  • 1 - 3

Datasets

Release 1.2